Tumour-targeting nanoparticles may spare patients from toxic chemotherapiesJune 17th, 2009 - 1:06 pm ICT by ANI
Washington, June 17 (ANI): Scientists at the University of Central Florida say that they have created nanoparticles that may someday come to be used for targeting and destroying tumours, marking the end of toxic chemotherapies.
J. Manuel Perez, an assistant professor at the university, has revealed that the nanoparticles designed by his team carry Taxol, one of the most widely used chemotherapeutic drugs.
Taxol normally causes many negative side effects because it travels throughout the body and damages healthy tissue as well as cancer cells.
Considering this, Perez and his colleagues have engineered the Taxol-carrying nanoparticles in such a manner that they carry the drug only to the cancer cells, allowing targeted cancer treatment without harming healthy cells.
The researcher have revealed that they could achieve this by attaching a vitamin (folic acid) derivative that cancer cells like to consume in high amounts.
The nanoparticles also carry a fluorescent dye and an iron oxide magnetic core, which is why their locations within the cells and the body can be seen by optical imaging and magnetic resonance imaging (MRI).
This will enable doctors to see how a tumour is responding to the treatment.
The researchers say that the nanoparticles also can be engineered without the drug and used as imaging agents for cancer.
According to them, if there is no cancer, the biodegradable nanoparticles will not bind to the tissue and will be eliminated by the liver.
“What’s unique about our work is that the nanoparticle has a dual role, as a diagnostic and therapeutic agent in a biodegradable and biocompatible vehicle,” Perez said.
“Our work is an important beginning, because it demonstrates an avenue for using nanotechnology not only to diagnose but also to treat cancer, potentially at an early stage,” Perez said.
A research artcil eon this work has been published in the journal Small. (ANI)
- Soon, localized delivery of anti-cancer drug by remote-controlled microcarriers - Mar 16, 2011
- Magnets help fight prostate cancer - Nov 09, 2011
- Promising new cancer treatment 'fries' cells inside tumors - Nov 24, 2010
- Cancer drug shows promise in regeneration of spinal cord injuries - Jan 29, 2011
- Scientists introduce thermotherapy as a chemotherapy alternative - Nov 23, 2010
- New invention could improve cancer drug delivery - Dec 24, 2010
- 'Breast on-a-chip' to help experts in cancer research - Jan 25, 2011
- New therapy shows promise against brain cancer - Feb 02, 2011
- New ultrasound technology can accurately spot prostate cancer tumours - Dec 09, 2010
- New 'nanodrug' can attack breast cancer cells from the inside out - Mar 30, 2011
- Light sensitive drugs to target cancer - Jun 05, 2011
- Viagra, anti-cancer drug combo shrinks tumors in vivo - Sep 28, 2010
- Now, 'Trojan Horse' delivery system to attack cancer cells from inside - Jul 28, 2010
- Cancer cells can be 'burned up' using magnetic pulses - Dec 06, 2010
- New guerrilla tactics could outwit cancer cells - Sep 05, 2012
Tags: assistant professor, cancer cells, cancer treatment, central florida, chemotherapies, derivative, dual role, iron oxide, magnetic core, magnetic resonance imaging, magnetic resonance imaging mri, manuel perez, nanoparticle, nanoparticles, optical imaging, resonance imaging mri, taxol, therapeutic agent, tumours, university of central florida